193 related articles for article (PubMed ID: 16803531)
1. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus.
Wong L; See HT; Khoo-Tan HS; Low JS; Ng WT; Low JJ
Int J Gynecol Cancer; 2006; 16(3):1364-9. PubMed ID: 16803531
[TBL] [Abstract][Full Text] [Related]
2. Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus.
Manolitsas TP; Wain GV; Williams KE; Freidlander M; Hacker NF
Cancer; 2001 Apr; 91(8):1437-43. PubMed ID: 11301390
[TBL] [Abstract][Full Text] [Related]
3. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
4. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB
Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
[TBL] [Abstract][Full Text] [Related]
6. Malignant mixed Mullerian tumors.
Ruiz Tovar J; Reguero Callejas ME; Arano Bermejo JI; Capote Armas LF; González-Palacios Martínez F; Cabañas Navarro L
Clin Transl Oncol; 2006 Feb; 8(2):129-32. PubMed ID: 16632428
[TBL] [Abstract][Full Text] [Related]
7. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Dusenbery KE; Potish RA; Argenta PA; Judson PL
Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone.
Pautier P; Rey A; Haie-Meder C; Kerbrat P; Dutel JL; Gesta P; Bryard F; Morice P; Duvillard P; Lhommé C
Int J Gynecol Cancer; 2004; 14(6):1112-7. PubMed ID: 15571617
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
[TBL] [Abstract][Full Text] [Related]
10. Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
Ozguroglu M; Bilici A; Ilvan S; Turna H; Atalay B; Mandel N; Sahinler I
Int J Gynecol Cancer; 2008; 18(4):809-12. PubMed ID: 17892455
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma of the ovary-a case series.
Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
[TBL] [Abstract][Full Text] [Related]
13. Eleven years: the long and winding road.
Ramondetta LM; Jhingran A
Gynecol Oncol; 2007 Nov; 107(2):166-8. PubMed ID: 17950382
[No Abstract] [Full Text] [Related]
14. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
[TBL] [Abstract][Full Text] [Related]
15. Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy.
Mok JE; Kim YM; Jung MH; Kim KR; Kim DY; Kim JH; Kim YT; Nam JH
Int J Gynecol Cancer; 2006; 16(1):101-5. PubMed ID: 16445618
[TBL] [Abstract][Full Text] [Related]
16. [Multimodal treatment of malignant mixed Müllerian tumor].
Kalincsák J; Gőcze P; Bódis J; Kovács K; Stefanovits Á; Bohonyi N; Péntek S; Papp S
Orv Hetil; 2018 May; 159(19):741-747. PubMed ID: 29730944
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Sit AS; Price FV; Kelley JL; Comerci JT; Kunschner AJ; Kanbour-Shakir A; Edwards RP
Gynecol Oncol; 2000 Nov; 79(2):196-200. PubMed ID: 11063643
[TBL] [Abstract][Full Text] [Related]
20. Early-stage carcinosarcoma of the uterus: the significance of lymph node count.
Temkin SM; Hellmann M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2007; 17(1):215-9. PubMed ID: 17291256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
